HCVax (lentiviral based HCV immunotherapy)
/ GeneCure Biotechnologies
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 29, 2021
Therapeutic Hepatitis C Virus Vaccine
(clinicaltrials.gov)
- P1; N=30; Recruiting; Sponsor: GeneCure Biotechnologies; Trial completion date: Dec 2022 ➔ Dec 2023; Trial primary completion date: Feb 2022 ➔ Feb 2023
Clinical • Trial completion date • Trial primary completion date • Hepatitis C • Hepatology • Infectious Disease • Inflammation • CD4 • IFNG • IL2
April 22, 2020
Therapeutic Hepatitis C Virus Vaccine
(clinicaltrials.gov)
- P1; N=30; Recruiting; Sponsor: GeneCure Biotechnologies; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Hepatitis C Virus • Infectious Disease
March 24, 2020
Therapeutic Hepatitis C Virus Vaccine
(clinicaltrials.gov)
- P1; N=30; Not yet recruiting; Sponsor: GeneCure Biotechnologies
Clinical • New P1 trial
1 to 3
Of
3
Go to page
1